A Treatment Continuation Study for Patients With Amyotrophic Lateral Sclerosis/Motor Neuron Disease Who Have Successfully Complete Study CMD-2019-001
Latest Information Update: 18 Feb 2022
At a glance
- Drugs Cu(II) ATSM (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
Most Recent Events
- 15 Feb 2022 Status changed from recruiting to completed.
- 15 Mar 2020 Status changed from planning to recruiting.
- 16 Jan 2019 New trial record